Award

NIH Reporter #5R37CA285434-03

Development and validation of an autologous mouse model for the study of immune interactions with glioblastoma

Recipient

University of Pennsylvania, Philadelphia, PA, United States

Award Amount

$727,211.00

Ceiling

$727,211.00

Awarded

June 03, 2026

Identifier

5R37CA285434-03

This award supports the development and validation of an autologous humanized mouse model to study immunotherapies in glioblastoma, using tumor tissue and matched immune cells from the same patient to ensure clinically relevant experimental outcomes.

Description

An autologous mouse model for glioblastoma immunotherapy research, developed by engrafting human immune system components, tumor tissue, and T cells from the same patient, allowing for relevant preclinical evaluation of immune responses and therapies.

View original record